Neuberger Berman High Yield Strategies Fund Stock Price and Value Analysis

Should you buy Neuberger Berman High Yield Strategies Fund stock? (NYSE American:NHS). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
  • This company has a large dividend yield!
  • This company has amazingly consistent growth!
  • This stock looks overpriced.
  • This company is not making money.
  • This company is less known than others.

Inside the NHS Numbers

NHS Price
(Neuberger Berman High Yield Strategies Fund stock price per share)
$8.85
[?] PE Ratio versus Sector 330% higher than other Financial stocks
[?] PE Ratio versus Industry 226% higher than other Asset Management stocks
[?] Free Cash Flow Jitter 0%
[?] Dividend Yield 14%
Shares Shorted 6,955

Is Neuberger Berman High Yield Strategies Fund Stock on Sale?

Based on our analysis, we believe that you should not buy Neuberger Berman High Yield Strategies Fund right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy NHS Stock?

Does Neuberger Berman High Yield Strategies Fund have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.